Diisononyl phthalate aggravates allergic dermatitis by activation of NF-kB

Oncotarget. 2016 Dec 20;7(51):85472-85482. doi: 10.18632/oncotarget.13403.

Abstract

Several epidemiological studies have suggested a possible link between exposure to Diisononyl phthalate (DINP) and the development of allergies. These findings remain controversial since there is insufficient scientific evidence to assess the ability of DINP to influence allergic immune responses. In addition, the mechanisms behind DINP-caused allergic diseases have not been fully elucidated. In this study, Balb/c mice were orally exposed to DINP for 3 weeks and were then sensitized with fluorescein isothiocyanate (FITC). We showed that oral exposure to DINP could aggravate allergic-dermatitis-like lesions, indicated by an increase in the number of mast cells, and in increased skin edema in FITC-induced contact hypersensitivity. This deterioration was concomitant with increased total serum immunoglobulin-E and Th2 cytokines. We determined the oxidative damage and the activation of nuclear factor-kb (NF-kB). The data demonstrated that DINP could promote oxidative damage and the activation of NF-kB in the skin. The expression of thymic stromal lymphopoietin and the activation of signal transducer and activator of transcriptions 3, 5 and 6 were enhanced concomitant with exacerbated allergic dermatitis effects and the activation of NF-kB induced by DINP. These effects were alleviated by pyrollidine dithiocarbamate, an inhibitor of NF-kB. The results suggest that oral exposure to DINP aggravated allergic contact dermatitis, which was positively regulated via NF-kB.

Keywords: NF-kB; allergic dermatitis; diisononyl phthalate (DINP); oxidative stress; thymic stromal lymphopoietin (TSLP).

MeSH terms

  • Administration, Oral
  • Animals
  • Cytokines / blood
  • Cytokines / metabolism
  • Dermatitis, Allergic Contact / etiology*
  • Dermatitis, Allergic Contact / immunology
  • Dermatitis, Allergic Contact / metabolism
  • Dermatitis, Allergic Contact / pathology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Fluorescein-5-isothiocyanate*
  • Immunoglobulin E / blood
  • Male
  • Mice, Inbred BALB C
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism*
  • Oxidative Stress / drug effects
  • Phthalic Acids / administration & dosage
  • Phthalic Acids / toxicity*
  • Pyrrolidines / pharmacology
  • STAT Transcription Factors / metabolism
  • Signal Transduction / drug effects
  • Skin / drug effects*
  • Skin / immunology
  • Skin / metabolism
  • Skin / pathology
  • Th2 Cells / drug effects
  • Th2 Cells / immunology
  • Th2 Cells / metabolism
  • Thiocarbamates / pharmacology
  • Thymic Stromal Lymphopoietin

Substances

  • Cytokines
  • NF-kappa B
  • Phthalic Acids
  • Pyrrolidines
  • STAT Transcription Factors
  • Thiocarbamates
  • pyrrolidine dithiocarbamic acid
  • Immunoglobulin E
  • diisononyl phthalate
  • Fluorescein-5-isothiocyanate
  • Thymic Stromal Lymphopoietin
  • TSLP protein, mouse